We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

13 hedge funds and large institutions have $1.01M invested in Quoin Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,124% more capital invested

Capital invested by funds: $82.2K → $1.01M (+$924K)

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

86% more funds holding

Funds holding: 7 → 13 (+6)

0.42% more ownership

Funds ownership: 0.12% → 0.54% (+0.42%)

Holders
13
Holders Change
+6
Holders Change %
+85.71%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$348K
2
ACM
Altium Capital Management
New York
+$185K
3
IC
Ikarian Capital
Texas
+$180K
4
Renaissance Technologies
Renaissance Technologies
New York
+$61.9K
5
BFM
Boothbay Fund Management
New York
+$52.9K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$13K
2
UBS Group
UBS Group
Switzerland
-$11.8K
3
JP Morgan Chase
JP Morgan Chase
New York
-$326
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$345K +$348K +15,143 New
ACM
2
Altium Capital Management
New York
$184K +$185K +8,064 New
IC
3
Ikarian Capital
Texas
$179K +$180K +7,857 New
Renaissance Technologies
4
Renaissance Technologies
New York
$86.6K +$61.9K +2,698 +244%
BFM
5
Boothbay Fund Management
New York
$52.5K +$52.9K +2,306 New
AWM
6
Apollon Wealth Management
South Carolina
$52.1K +$52.5K +2,286 New
TSS
7
Two Sigma Securities
New York
$34.2K +$13.6K +591 +65%
XT
8
XTX Topco
Cayman Islands
$20.2K +$20.4K +887 New
HF
9
HRT Financial
New York
$18K +$18.2K +792 New
Raymond James Financial
10
Raymond James Financial
Florida
$16.3K +$16.5K +718 New
RhumbLine Advisers
11
RhumbLine Advisers
Massachusetts
$15.7K +$2.18K +95 +16%
UBS Group
12
UBS Group
Switzerland
$3.11K -$11.8K -516 -79%
SS
13
SBI Securities
Japan
$16 +$23 +1 New
RBI
14
Raiffeisen Bank International
Austria
$11 – – –
HNB
15
Huntington National Bank
Ohio
$6 – – –
VF
16
Virtu Financial
New York
– -$13K -719 Closed
JP Morgan Chase
17
JP Morgan Chase
New York
– -$326 -18 Closed

QNRX Hedge Fund Activity: Q4 2024 in Review

13 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q4 2024, worth a combined $1.01M — up 1,124% from $82.2K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new QNRX positions and 2 closed out — a net gain of 7 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $348K. The largest seller was Virtu Financial, exiting entirely with an estimated $13K sold.

  • 13 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q4 2024, up from 7 in Q3 2024.
  • Funds reported $1.01M of Quoin Pharmaceuticals stock for Q4 2024, up 1,124% quarter-over-quarter.
  • 9 funds opened new Quoin Pharmaceuticals positions in Q4 2024 and 2 closed out, a net change of +7 holders.
  • The largest Quoin Pharmaceuticals buyer in Q4 2024 was Armistice Capital, an estimated $348K added.
  • The largest Quoin Pharmaceuticals seller in Q4 2024 was Virtu Financial, an estimated $13K sold.

Based on aggregated 13F filings for Q4 2024.